SSRIs are the most widely recommended medications for panic attacks and panic disorder. Three SSRIs have FDA approval specifically for panic disorder: fluoxetine (Prozac), paroxetine (Paxil), and sertraline (Zoloft). One SNRI, venlafaxine (Effexor XR), is also FDA-approved for this condition. These are long-term, daily medications designed to prevent panic attacks from happening in the first place, and they’re the standard starting point for treatment.
How Daily Medications Prevent Panic Attacks
SSRIs and SNRIs work by keeping more serotonin (and in the case of SNRIs, norepinephrine) active in your brain. Normally, after these chemical messengers deliver a signal between brain cells, your brain reabsorbs them. These medications block that reabsorption, so serotonin and norepinephrine stay available longer. Over time, this stabilizes the brain circuits involved in fear and anxiety, making it harder for a panic attack to fire off.
The catch is that these medications aren’t instant. They typically take four to six weeks after reaching a therapeutic dose to show their full effect. For some people, it can take nine to 12 weeks. During the first week or two, you may actually feel more anxious, jittery, or restless before things improve. This is a well-known early side effect that usually fades as your body adjusts. Most side effects ease within the first couple of weeks, though some can linger.
Because of this adjustment period, doctors often start at a low dose and gradually increase. For fluoxetine, a typical starting dose is 10 mg daily, working up to a therapeutic range of 20 to 60 mg. For sertraline, the starting dose is usually 25 mg, with the therapeutic range between 100 and 200 mg. Venlafaxine generally starts at 37.5 mg and works up to 150 to 225 mg. Starting low is especially important for people with panic disorder, since they tend to be more sensitive to the initial activation side effects.
Which SSRI Works Best
A large network meta-analysis published in The BMJ compared multiple drug classes across randomized controlled trials and found that SSRIs, SNRIs, benzodiazepines, and tricyclic antidepressants all produced significantly higher remission rates than placebo. Remission in these studies meant having no panic attacks for at least one week by the end of the trial.
Among individual SSRIs, sertraline and escitalopram stood out for providing high remission rates with an acceptable level of side effects. The UK’s National Institute for Health and Care Excellence (NICE) recommends an SSRI as the first-line medication for panic disorder. If the first SSRI doesn’t work or causes intolerable side effects, the guidance is to try a different SSRI or switch to an SNRI like venlafaxine.
There’s no single “best” SSRI for everyone. The choice often comes down to your side effect profile, other medications you take, and how your body responds. It’s common to try more than one before landing on the right fit.
Benzodiazepines for Immediate Relief
While SSRIs prevent panic attacks over time, benzodiazepines like alprazolam (Xanax), clonazepam (Klonopin), and lorazepam (Ativan) can stop a panic attack within minutes. They work by calming brain activity quickly, which is why they’re sometimes prescribed as short-term rescue medications, particularly during the weeks before an SSRI takes full effect.
In clinical trials, benzodiazepines actually ranked highest among all drug classes for panic attack remission, with an 84.5% probability of being the best treatment. But that effectiveness comes with a significant downside: dependence. The largest risk factor for benzodiazepine misuse is having a current or past substance use disorder, but younger age, chronic sleep problems, and chronic illness also increase risk. Smoking and regular alcohol use are associated with roughly 1.5 to 1.8 times higher odds of chronic benzodiazepine use lasting two or more years.
NICE guidelines explicitly recommend against prescribing benzodiazepines for panic disorder in primary care settings. When they are prescribed, the expectation is short-term use only. Stopping after long-term use requires a slow, individualized taper over weeks to months. Doctors sometimes switch patients from a short-acting benzodiazepine to a longer-acting one before tapering, and adding cognitive behavioral therapy during the process improves outcomes. Exercise, interestingly, acts as a protective factor against chronic benzodiazepine use.
Non-Addictive Alternatives for Acute Symptoms
If benzodiazepines carry too much risk, two other options are sometimes used off-label for panic-related symptoms. Neither is a controlled substance.
- Propranolol is a beta-blocker that blunts the physical symptoms of panic, specifically the racing heart, trembling, and sweating. It doesn’t directly reduce the psychological fear, but by quieting the body’s adrenaline response, it can break the feedback loop where physical symptoms fuel more panic. It’s commonly used for performance anxiety and is sometimes prescribed for panic disorder.
- Hydroxyzine is an antihistamine with calming effects. It causes sedation, which can take the edge off acute anxiety when other treatments aren’t appropriate. It’s typically a backup option rather than a first choice.
Neither of these is as fast-acting or as potent for full-blown panic attacks as a benzodiazepine, but they avoid the dependency risk entirely.
What Treatment Typically Looks Like
For most people, treatment starts with a daily SSRI at a low dose, with check-ins every one to two weeks during the early phase. Your doctor will monitor how you’re tolerating side effects and whether the dose needs adjusting. If the first SSRI doesn’t help after an adequate trial (usually six to eight weeks at a therapeutic dose), switching to another SSRI or to venlafaxine is the standard next step.
Some people are prescribed a short course of a benzodiazepine to bridge the gap while the SSRI takes effect, though this approach is becoming less common due to dependency concerns. Medication is most effective when combined with therapy, particularly cognitive behavioral therapy, which teaches you to recognize and interrupt the thought patterns that trigger and sustain panic attacks.
NICE guidelines also specifically recommend against using sedating antihistamines or antipsychotics as treatments for panic disorder in primary care. These are sometimes brought up as possibilities, but the evidence doesn’t support them as standard options.
Medications to Avoid or Use Cautiously
Tricyclic antidepressants (older medications like imipramine and clomipramine) do work for panic disorder and ranked second in clinical trials for remission. But they carry more side effects than SSRIs, including dry mouth, constipation, weight gain, dizziness, and cardiac effects. They’re generally reserved for cases where SSRIs and SNRIs have both failed.
Monoamine oxidase inhibitors (MAOIs) also showed effectiveness in trials but require strict dietary restrictions and carry serious interaction risks with common foods and medications. They’re rarely prescribed for panic disorder today.
The overall treatment landscape for panic attacks is well-established. SSRIs remain the starting point because they offer the best balance of effectiveness, safety, and tolerability. Most people find significant relief once the right medication and dose are identified, even if it takes some patience to get there.